Should You Be Concerned About COVID Vaccine Efficacy Against the South African Variant?

1 min read

COVID-19 vaccines from Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) are being distributed across the U.S. (and across the world, for that matter). But these vaccines received Emergency Use Authorization before the emergence of new coronavirus variants. One of those variants, first identified in South Africa, could especially present problems.

In this Motley Fool Live video recorded on Feb. 1, Motley Fool contributors Keith Speights and Danny Vena discuss whether or not Americans should be concerned about COVID-19 vaccine efficacy against the new South African variant.

Continue reading

Leave a Reply

Your email address will not be published.

Previous Story

Got $3000? Here Are 3 Solar Stocks to Buy and Hold for the Long Term

Next Story

Boston Beer Earnings: What to Watch

Latest from Blog